Tags: Neurotransmitters

announcements

$2.5 Million in New Grants Advance Clinical Trials of Alzheimer’s Treatments

We awarded three new grants in November and December, totaling nearly $2.5 million. The grants represent our commitment to advancing the most promising drugs to clinical trials, the final stages of drug development.  

announcements

Five New Research Grants Support Clinical and Early-Stage Programs

Funded Researchers are pursuing diverse targets to treat Alzheimer's disease.

announcements

ADDF and Harrington Discovery Institute Announce 2015 Award Recipients

Collaboration advances development of therapeutics for the treatment of Alzheimer’s Disease.

announcements

Grantees at Lou Rovo Center for Brain Health Recruiting for New Alzheimer's Disease Trial

Cleveland Clinic Lou Ruvo Center for Brain Health is recruiting participants for a trial to determine if treatment with rasagiline improves brain glucose metabolism and memory.

announcements

ADDF and Harrington Discovery Institute Announce 2014 Award Recipients

Researchers from The Ohio State and Emory Universities will be the first recipients of drug discovery funding and innovation support from a new partnership between the ADDF and Harrington Discovery Institute.

announcements

Alzheimer’s Drug Discovery Foundation Raises $1.1M for New Clinical Trial in Alzheimer’s

The ADDF raised more than $1.1 million at its Eighth Annual Connoisseur's Dinner to go to Jeffrey Cummings, MD in support of a clinical trial for a repurposed drug for treating Alzheimer's disease.